Cargando…
Comparison of treatment efficacy between 100% platelet-rich plasma and 100% serum eye drops in moderate-to-severe dry eye disease: a randomised controlled trial protocol
INTRODUCTION: Dry eye disease (DED) is a common eye problem. Although the disease is not fatal, it substantially reduces quality of life and creates a high economic burden, especially in patients with moderate-to-severe DED. Several biological tear substitutes (eg, autologous serum (AS), autologous...
Autores principales: | Jongkhajornpong, Passara, Numthavaj, Pawin, Anothaisintawee, Thunyarat, Lekhanont, Kaevalin, McKay, Gareth, Attia, John, Thakkinstian, Ammarin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246355/ https://www.ncbi.nlm.nih.gov/pubmed/34193498 http://dx.doi.org/10.1136/bmjopen-2020-048479 |
Ejemplares similares
-
Short-term Efficacy and Safety of Biological Tear Substitutes and Topical Secretagogues for Dry Eye Disease: A Systematic Review and Network Meta-analysis
por: Jongkhajornpong, Passara, et al.
Publicado: (2022) -
Undiluted Serum Eye Drops for the Treatment of Persistent Corneal Epitheilal Defects
por: Lekhanont, Kaevalin, et al.
Publicado: (2016) -
Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular Surgery
por: Lekhanont, Kaevalin, et al.
Publicado: (2013) -
Erratum to “Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular Surgery”
por: Lekhanont, Kaevalin, et al.
Publicado: (2014) -
Prevalence and risk factors of dry eye disease among University Students in Bangkok, Thailand
por: Supiyaphun, Chantaka, et al.
Publicado: (2021)